{"id":"https://openalex.org/W2805535134","doi":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","title":"Impact of Payload Hydrophobicity on the Stability of Antibody\u2013Drug Conjugates","display_name":"Impact of Payload Hydrophobicity on the Stability of Antibody\u2013Drug Conjugates","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-29","ids":{"openalex":"https://openalex.org/W2805535134","doi":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","mag":"2805535134","pmid":"https://pubmed.ncbi.nlm.nih.gov/29809017"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.8b00177","doi":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2805535134"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016481982","display_name":"Jakob W. Buecheler","orcid":"https://orcid.org/0000-0002-4799-2575","observed_orcids":["https://orcid.org/0000-0002-4799-2575"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jakob W. Buecheler","raw_affiliation_strings":["Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany","Division of Pharmaceutics, Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]},{"raw_affiliation_string":"Division of Pharmaceutics, Friedrich-Alexander Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081945709","display_name":"Matthias Winzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Winzer","raw_affiliation_strings":["Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007186059","display_name":"Jason Tonillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jason Tonillo","raw_affiliation_strings":["Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christian Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Weber","raw_affiliation_strings":["Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery and Development Technologies, Merck KGaA, 64293 Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049176376","display_name":"Henning Gieseler","orcid":"https://orcid.org/0000-0002-6638-3839","observed_orcids":["https://orcid.org/0000-0002-6638-3839"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Henning Gieseler","raw_affiliation_strings":["GILYOS GmbH, 97076 W\u00fcrzburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-6638-3839","affiliations":[{"raw_affiliation_string":"GILYOS GmbH, 97076 W\u00fcrzburg, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5049176376"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.6521,"has_fulltext":false,"cited_by_count":145,"citation_normalized_percentile":{"value":0.9391287,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"15","issue":"7","first_page":"2656","last_page":"2664"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7616999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7616999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.17900000512599945,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.996999979019165},{"id":"https://openalex.org/keywords/adc-stability","display_name":"ADC stability","score":0.7850000262260437},{"id":"https://openalex.org/keywords/octanol-water-partition-coefficient","display_name":"octanol-water partition coefficient","score":0.6129999756813049},{"id":"https://openalex.org/keywords/topological-polar-surface-area","display_name":"topological polar surface area","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-to-antibody-ratio","display_name":"drug-to-antibody ratio","score":0.7160000205039978},{"id":"https://openalex.org/keywords/igg1-monoclonal-antibody","display_name":"IgG1 monoclonal antibody","score":0.8040000200271606},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/protein-self-association","display_name":"protein self-association","score":0.8930000066757202},{"id":"https://openalex.org/keywords/biolayer-interferometry","display_name":"biolayer interferometry","score":0.609000027179718},{"id":"https://openalex.org/keywords/size-exclusion-hplc","display_name":"size-exclusion HPLC","score":0.7089999914169312},{"id":"https://openalex.org/keywords/differential-scanning-fluorimetry","display_name":"differential scanning fluorimetry","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7396801114082336},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6809208393096924},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5656706094741821},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.5333502292633057},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4819795489311218},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4175850450992584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36000221967697144},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.26434075832366943},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24534839391708374},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17316719889640808},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.16752609610557556},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.10100999474525452},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0},{"id":"https://openalex.org/C158379750","wikidata":"https://www.wikidata.org/wiki/Q214111","display_name":"Network packet","level":2,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067493","descriptor_name":"Dynamic Light Scattering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005470","descriptor_name":"Fluorometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.8b00177","doi":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.8b00177","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:29809017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29809017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W241951184","https://openalex.org/W1524815067","https://openalex.org/W1966000502","https://openalex.org/W2023546757","https://openalex.org/W2031237950","https://openalex.org/W2039484130","https://openalex.org/W2041182686","https://openalex.org/W2043028214","https://openalex.org/W2044464784","https://openalex.org/W2046522614","https://openalex.org/W2052432236","https://openalex.org/W2055973049","https://openalex.org/W2062458432","https://openalex.org/W2063142069","https://openalex.org/W2074980333","https://openalex.org/W2078317394","https://openalex.org/W2082024178","https://openalex.org/W2099758152","https://openalex.org/W2110051451","https://openalex.org/W2111877521","https://openalex.org/W2118964148","https://openalex.org/W2128485227","https://openalex.org/W2141209764","https://openalex.org/W2153942473","https://openalex.org/W2154302491","https://openalex.org/W2171368669","https://openalex.org/W2264135667","https://openalex.org/W2277737065","https://openalex.org/W2320097108","https://openalex.org/W2321980425","https://openalex.org/W2336727087","https://openalex.org/W2343344537","https://openalex.org/W2518692631","https://openalex.org/W2607719113","https://openalex.org/W2620705826","https://openalex.org/W2652934218","https://openalex.org/W2741504978"],"related_works":["https://openalex.org/W4395667008","https://openalex.org/W3014737468","https://openalex.org/W4390781781","https://openalex.org/W2811178999","https://openalex.org/W7204625795","https://openalex.org/W4282944162","https://openalex.org/W3004766944","https://openalex.org/W7119091834","https://openalex.org/W4385728358","https://openalex.org/W1524815067"],"abstract_inverted_index":{"In":[0,178],"silico":[1],"screening":[2],"of":[3,14,44,74,81,99,102,114,131,158,170],"toxin":[4,50],"payloads":[5,39,84],"typically":[6],"employed":[7],"in":[8],"ADCs":[9,60],"revealed":[10,124],"a":[11,75,86,90,125],"wide":[12],"range":[13,43],"hydrophobicities":[15],"and":[16,23,109,118,136,188,204,211],"sizes":[17],"as":[18],"measured":[19],"by":[20,47,67,145,194],"log":[21],"P":[22],"topological":[24],"polar":[25],"surface":[26],"area":[27],"(tPSA)":[28],"values.":[29],"These":[30],"descriptors":[31],"were":[32,61],"used":[33],"to":[34,56,69,85,162,174,191,200],"identify":[35],"three":[36],"nontoxic":[37],"surrogate":[38,65,83],"that":[40,183],"encompass":[41],"the":[42,48,70,100,129,132,137,159,168,175,184,195],"hydrophobicity":[45,104,198],"defined":[46],"ADC":[49,202],"training":[51],"set.":[52],"The":[53,112],"uniform":[54],"drug":[55],"antibody":[57],"ratio":[58],"(DAR)":[59],"prepared":[62],"for":[63,95],"each":[64],"payload":[66,103,139,176,197],"conjugation":[68],"interchain":[71],"cysteine":[72],"residues":[73],"model":[76],"IgG1":[77],"subtype":[78],"mAb.":[79],"Linkage":[80],"these":[82,180],"common":[87],"mAb":[88,134,161],"with":[89,155,167],"matched":[91],"DAR":[92],"value":[93],"allowed":[94],"preliminary":[96],"analytical":[97],"interrogation":[98],"influence":[101],"on":[105],"global":[106],"structure,":[107],"self-association,":[108],"aggregation":[110],"properties.":[111],"results":[113],"differential":[115],"scanning":[116],"fluorimetry":[117],"dynamic":[119],"light":[120],"scattering":[121],"experiments":[122],"clearly":[123],"direct":[126],"correlation":[127],"between":[128],"destabilization":[130,187],"native":[133],"structure":[135,186],"increasing":[138,196],"hydrophobicity.":[140,177],"Also,":[141],"self-association/aggregation":[142],"propensity":[143,190],"examined":[144],"self-interaction":[146],"biolayer":[147],"interferometry":[148],"or":[149],"size":[150],"exclusion":[151],"HPLC":[152],"was":[153],"consistent":[154],"increased":[156],"conversion":[157,171],"monomeric":[160],"higher":[163],"order":[164],"aggregated":[165],"species,":[166],"degree":[169],"directly":[172],"proportional":[173],"summary,":[179],"findings":[181],"prove":[182],"payload-dependent":[185],"enhanced":[189],"self-associate/aggregate":[192],"driven":[193],"contribute":[199],"reduced":[201],"stability":[203],"more":[205],"complex":[206],"behavior":[207],"when":[208],"assessing":[209],"exposure":[210],"safety/efficacy":[212],"relationships.":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2805535134","counts_by_year":[{"year":2026,"cited_by_count":42},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-06-13T00:00:00"}
